Evidence map›Paper›PMID 31569604›Full record

ArticleNutrients2019

Acute Kahweol Treatment Attenuates Traumatic Brain Injury Neuroinflammation and Functional Deficits.

Hung-Fu Lee, Jhih Syuan Lin, Che-Feng Chang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. [Kahweol improves motor function of mice with spinal cord injury by inhibiting microglial activationNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  3. The Effect ofNeuroSci · 2025
    Article
  4. Article
  5. Article
  6. The Active Components of Sunflower (Frontiers in nutrition · 2021
    Article
  7. Neuroprotective Effects of Coffee Bioactive Compounds: A Review.International journal of molecular sciences · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hung-Fu LeeDepartment of Neurosurgery, Cheng Hsin General Hospital, Taipei 11220, Taiwan. ufae0073@ms7.hinet.net.
Jhih Syuan LinDepartment of Neurosurgery, Cheng Hsin General Hospital, Taipei 11220, Taiwan. xup5@cycu.org.tw.
Che-Feng ChangGraduate Institute of Physiology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan. chefengchang@ntu.edu.tw.
Cheng Hsin General Hospital · TWNational Taiwan University · TW

Funding

Ministry of Science and Technology of Taiwan MOST 107-2320-B-002-063-MY2
6 · The paper itself

Abstract

Traumatic brain injury (TBI) affects millions worldwide with devastating long-term effects on health and cognition. Emerging data suggest that targeting the immune response may offer promising strategies to alleviate TBI outcomes; kahweol, an anti-inflammatory diterpene that remains in unfiltered coffee, has been shown to be beneficial in neuronal recovery. Here, we examined whether kahweol could alleviate brain trauma-induced injury in a mouse model of TBI and its underlying mechanisms. TBI was induced by controlled cortical impact (CCI) and various doses of kahweol were intraperitoneally administered following injury. Contusion volume, brain edema, neurobehavioral deficits, and protein expression and activity were evaluated in both short-term and long-term recovery. We found that kahweol treatments significantly reduced secondary brain injury and improved neurobehavioral outcomes in TBI mice. These changes were accompanied by the attenuation of proinflammatory cytokine secretion, decreased microglia/macrophage activation, and reduction of neutrophil and leukocyte infiltration. In addition, continuous kahweol treatment further improved short-term TBI outcomes compared to single-dosage. Collectively, our data showed that kahweol protects against TBI by reducing immune responses and may serve as a potential therapeutic intervention for TBI patients.

Indexed as

AnimalsAnti-Inflammatory AgentsBrain Injuries, TraumaticCytokinesDisease Models, AnimalDiterpenesLeukocytesMacrophagesMiceMicrogliaNeutrophil InfiltrationAnti-Inflammatory AgentsCytokinesDiterpeneskahweolcoffeecoffee diterpene kahweolinnate immunityleukocyte infiltrationneuroinflammationtraumatic brain injury

Identifiers

PMID31569604
PMCPMC6835740
OpenAlexW2975871115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.